Clover Health Investments, CORP /DE Form 4 insider transactions

Clover Health Investments Corp. insider Jamie L. Reynoso reports acquisition of 159,384 Class A common stock shares via restricted stock unit vesting.

Clover Health Investments, Corp. CEO Andrew Toy reported transactions involving Class A Common Stock, including the vesting of restricted stock units and the withholding of shares for tax obligations.

Conrad Wai, CEO of Clover Health Investments, Corp., reported transactions involving restricted stock units and shares held in trust.

Clover Health Investments Corp. Chief Legal Officer Karen Soares acquired 382,522 shares of Class A common stock through a restricted stock unit award.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported a planned sale of 5,833 shares of Class A Common Stock for a weighted average price of $1.91 per share under a pre-arranged 10b5-1 trading plan.

Clover Health CEO Conrad Wai reported a routine disposition of shares to cover tax obligations from RSU vesting.

Clover Health's CEO of Home Care, Brady Priest, reported the sale of 175,000 Class A Common Stock shares for $2.17 per share.

Clover Health CEO Andrew Toy disposed of 85,704 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CFO, Peter J. Kuipers, reported the disposition of 156,856 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health CEO Andrew Toy disposed of 60,764 Class A Common Stock shares on January 15, 2026, to cover tax liabilities from RSU vesting.

Clover Health General Counsel Karen Soares reported the automatic withholding of 11,686 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health CEO Conrad Wai reported a tax withholding of 25,868 shares of Class A Common Stock at $2.81 per share due to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported the sale of 4,597 shares and the withholding of 14,732 shares for tax obligations related to RSU vesting.

Clover Health's CEO of Home Care, Brady Priest, disposed of shares to cover tax obligations related to RSU vesting.

Clover Health Investments Director and 10% owner Vivek Garipalli reported the vesting of restricted stock units and subsequent share withholding for tax obligations.

Clover Health Investments director Demetrios L. Kouzoukas was granted 79,365 restricted stock units, vesting on January 6, 2027.

Clover Health Investments Corp. Director Carladenise Armbrister Edwards was granted 79,365 restricted stock units, vesting in one year.

Clover Health Investments Director Anna U. Loengard reported the acquisition of 79,365 restricted stock units and updated her beneficial ownership.

Clover Health Investments Corp. director William G. Robinson Jr. was granted 79,365 restricted stock units, vesting in January 2027.

Clover Health director Thomas L. Tran was granted 79,365 Class A Common Stock shares through a restricted stock unit award, increasing his beneficial ownership to 180,029 shares.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,102 shares of Class A Common Stock for $2.53 per share under a pre-arranged 10b5-1 trading plan.

Clover Health CEO Andrew Toy disposed of 267,958 Class A Common Stock shares on January 1, 2026, to cover tax liabilities from RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 8,109 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health Investments Corp.'s CEO of Medicare Advantage, Jamie L. Reynoso, sold 4,913 shares of Class A Common Stock for a weighted average price of $2.61 per share.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported the automatic withholding of shares to cover tax obligations related to RSU vestings on December 14 and 15, 2025.

Clover Health's CEO, Conrad Wai, disposed of 98,411 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, disposed of 6,404 Class A Common Stock shares at $2.70 each to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, disposed of 7,459 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health CEO Andrew Toy disposed of 85,535 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 30,385 shares of Class A Common Stock for a weighted average price of $3.58 per share.